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Abstract
All tumor cell lines that have been tested are defective for Myc auto-repression, and have high levels of Myc produced from
wild type loci and re-arranged loci. Like mammalian Myc auto-repression, Myc protein represses the expression of its gene,
dmyc, in Drosophila. This activity requires Polycomb (Pc), since RNAi for Pc in the embryo eliminates Myc auto-repression.
We have observed that upon depletion of Polycomb in the embryo, levels of one of 18 different chromatin-binding genetic
regulators, Su(z)2, rise dramatically. We pursued the possibility that increased levels of this protein, Su(z)2, interfere with
Myc auto-repression, potentially explaining the loss of auto-repression upon Pc RNAi. We report that embryos expressing
both ectopic Myc and ectopic Su(z)2 fail in Myc auto-repression. Surprisingly, histone H3K27 tri-methylation at the dmyc
locus is inversely correlated with the presence of auto-repression. We show phenotypic consequences of potent dmyc auto-
repression, and their complete reversal by ectopic Su(z)2: dmyc auto-repression induced a diminutive (dm) phenotype, and
upon elimination of auto-repression by Su(z)2, overall levels of Myc increased and completely rescued the phenotype. We
show that this increase in Myc levels caused dramatic activation of Myc activation targets. These data suggest that Su(z)2 is
capable of increasing the potency of Myc activity by eliminating Myc’s feedback regulation by auto-repression. Although
Su(z)2 eliminated Myc auto-repression, we found that Myc repression of other genes is not affected by Su(z)2. These data
suggest a unique antagonistic role for Su(z)2 in Myc auto-repression, and a potential mechanism for cancer-cell specific loss
of Myc auto-repression.
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Introduction
Myc protein is required for cell growth and proliferation in
Drosophila and mammals, and its function is conserved among all
metazoans, with the exception of nematodes [1,2,3]. Myc affects
transcription by inducing or repressing hundreds, if not thousands,
of target genes; Myc protein can bind to 11% of all human
promoters, with some sites bound in almost all cells and some sites
bound only at high Myc levels [4]. Genes regulated by Myc
include those that promote growth and proliferation and inhibit
differentiation [5]. Independent of DNA binding, Myc can affect
the phosphorylation state of the C-terminal domain of RNA
polymerase II, affecting RNA processing and translation [6].
Over-expression of Myc also affects DNA replication, modulating
origin of replication activity and leading to replication stress and
DNA damage [7]. These activities of Myc explain its potent
oncogenic activity.
Although equally important, the mechanism of Myc’s activity of
transcriptional repression is less well understood than its
mechanism of transcriptional activation. Myc is capable of
repressing targets when recruited to a promoter via another
transcription factor, such as Miz-1 [8]. In addition, Myc and its
heterodimerization partner, Max, have been found to bind to
promoters repressed by Myc independently of Miz-1 [9,10,11]. A
truncated version of Myc that fails in transcriptional activation is
still functional in repression, suggesting a mechanism of trans-
repression that is distinct from activation and does not require
Myc’s activation of co-repressors [12]. Newly discovered targets of
Myc repression include a set of microRNA genes, the repression of
which contributes to tumor formation. The promoters of these
genes are bound by Myc protein [13]. Therefore, binding of Myc
to promoters is important for repression, however the mechanism
by which it is recruited there is unknown.
Myc is capable of repressing its own gene, and this auto-
repression is disrupted in all cancer cell lines tested [14,15]. We
have shown previously that the chromatin binding repressor
Polycomb (Pc) is required for Myc to repress its own gene, dmyc,
in Drosophila [16]. Polycomb Group (PcG) proteins are known for
their role in regulation of gene expression necessary for cellular
differentiation, stem cell maintenance, and avoidance of tumor-
igenesis [17,18]. Polycomb group proteins work in large, multi-
subunit complexes that bind to and modify chromatin, silencing
hundreds of loci from flies to mammals [18,19,20,21,22,23,24,25].
Pc RNAi in the Drosophila embryo results in the loss of the
majority of trans-repression by Myc, among many other gene
expression changes [16,26]. Along with the decrease in repression
by Myc, we report here an increase in levels of Su(z)2, a PcG
related protein [27,28,29,30] that is required for ectopic Myc-
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increase in Su(z)2 alone disrupts auto-repression by Myc, but not
Myc repression of other targets. As a consequence of the loss of
auto-repression, we show that elevated levels of ectopic Myc lead
to an increase in Myc activation of its targets. These data provide
the first evidence for a protein that interferes with Myc auto-
repression, leading to elevated Myc levels and subsequent
increases in activation by Myc.
Results
Su(z)2 up-regulation results in the loss of auto-repression
by Myc
Ectopic Myc expression in Drosophila embryos results in the
repression of 80–200 genes, including the Drosophila myc (dmyc)
gene. Depletion of Polycomb by RNAi abrogates auto-repression
and the majority of Myc repression at mid embryogenesis [16,26].
A logical hypothesis for the role of Polycomb in Myc repression is
that it directly binds to and represses these targets. However, this
hypothesis is inconsistent with our previous results indicating that a
PcG protein required for the targeting of Polycomb, Pho, does not
play the same role in repression by Myc. Many Myc repression
targets affected by Polycomb are unaffected by depletion of Pho
[26]. Because Pho physically targets Polycomb to many loci
[32,33,34], we considered the possibility that Polycomb is not
directly targeted to all genes that Myc represses. Therefore, we
hypothesized that the role of Polycomb in repression by Myc is
indirect: Polycomb is required to repress a different gene or genes,
and that repression is required for Myc-induced repression
(Figure 1A).
If the role of Polycomb in repression by Myc is largely indirect,
then our genome-wide expression data [16,26] should provide
information regarding the gene or genes in the Myc-Polycomb
repression pathway. We began a search for candidate genes by
examining gene expression changes in any genes known to be
generally involved in chromatin binding and genetic regulation.
Therefore, we examined gene expression changes of many PcG
and Trithorax Group (TrxG) genes upon Pc RNAi in the embryo.
Among 18 such genes (pho, Psc, E(z), Su(z)2, Scm, ph-d, ph-p,
Sce/Ring, esc, z, Pcl, Asx, ash1, brm, trx, ash2, lid and Trl), only
Su(z)2 levels changed significantly upon Pc RNAi: Su(z)2
transcripts increased 4-fold upon Pc RNAi (Figure 1B, microarray
data are described in Goodliffe et al. 2007). These data indicated
that Pc is required for repression of Su(z)2, which is consistent with
previous reports of cross-regulation among PcG members [35].
We were intrigued by these data, because Su(z)2 is a functional
homolog of the PcG protein Psc, and known to be a potent
repressor when targeted to loci by LexA fusion [29,36,37,38]. Our
data suggested the potential for Su(z)2 to affect auto-repression by
Myc, and despite the unexpected potential for a repressor to
interfere with repression, we pursued the possibility.
We considered two hypotheses: 1) that Pc is required for direct
repression by Myc and Su(z)2 levels are incidental, or 2) that
Su(z)2 blocks repression by Myc and Polycomb is required to
repress the Su(z)2 gene (Figure 1A, where gene Y represents
Su(z)2). To determine whether the latter hypothesis is true, we
obtained flies from the Exelixis collection that contain an XP
insertion near the endogenous Su(z)2 locus (P[XP]d01221,
abbreviated here as Su(z)2XP) [39], leading to its ectopic
expression under the control of Gal4 as detected by RT-PCR
Figure 1. Pc RNAi results in an increase in Su(z)2 levels. A) We suggest two possible scenarios for the role of Pc in Myc auto-repression: Pc is
either directly involved with Myc protein in repression (left), or required to repress a third player, gene Y (right), whose protein product interferes with
Myc repression (right). B) A candidate for gene Y. See Goodliffe et al., 2007, for microarray data generation. Log2 ratios of changes in levels of 19 PcG
and TrxG transcripts are shown, compared to wild type levels (Gal4), in embryos with ectopic Myc (blue), ectopic Myc plus Pc RNAi (red) and ectopic
Myc plus pho RNAi (green).
doi:10.1371/journal.pone.0005076.g001
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ectopic Su(z)2, and the combination of both under the control of
an armadillo-Gal4 driver (see Materials and Methods for genetic
crosses).
In embryos with ectopic Myc, endogenous dmyc gene
expression was reduced compared to wild type. In contrast,
simultaneous ectopic Myc and ectopic Su(z)2 expression resulted
in a dramatic increase in endogenous dmyc expression compared to
levels in embryos expressing ectopic Myc alone (P=0.036 by
Student’s t-test, Figure 2A–B). These results suggest that, at the
minimum, Su(z)2 expression interferes with dmyc auto-repression.
Because endogenous dmyc levels were also increased over wild
type levels, ectopic Su(z)2 and Myc together appear to cause an
activation of endogenous Myc in addition to relief of auto-
repression. In fact, increased levels of Su(z)2 alone appear to
induce endogenous dmyc, though to a lesser degree than with
ectopic Su(z)2 and Myc together. These results suggest the
importance of wild type dmyc auto-repression, which when
disrupted, may allow induction of the dmyc gene in the embryo
potentially by the mitogenic signals that are likely to be operating
during embryogenesis.
We considered the possibility that Su(z)2 may interfere with
Myc protein levels, accounting for the failure of auto-repression.
We obtained an antibody specific for Drosophila Myc, and
compared its staining with fluorescent in situ hybridization (FISH)
to dmyc transcripts in wild type embryos (data not shown and Fly-
FISH [40]). Because we observed the same staining pattern with
both FISH and immuno-staining using the anti-Myc antibody, we
examined levels of Myc protein in embryos of four genotypes
(armGal4, armGal4-UAS dmyc, armGal4-Su(z)2XP, armGal4-
UAS dmyc-Su(z)2XP). We found that ectopic Su(z)2 does not
decrease Myc protein levels (Figure 3). In fact, we found that
embryos expressing ectopic Myc have reduced total Myc protein
levels, and those expressing both ectopic Myc and ectopic Su(z)2
have wild type levels of Myc (Figure 3). These results are consistent
with our RT-PCR data and indicate that increased levels of Su(z)2
provide increased Myc protein levels in the absence of auto-
repression.
In these experiments, we found that armGal4 provided low
levels of ectopic Myc compared to wild type levels found in
embryos. As shown in Figures 2–3, total Myc levels are high in
Gal4, non-ectopic Myc expressing embryos. In embryos with
ectopic Myc, endogenous Myc levels dropped dramatically, and
therefore the total Myc levels must have consisted of mostly
ectopic Myc. When the levels of ectopic Myc were lower than Myc
levels that occur in wild type embryos, transgenic, dmyc auto-
repressing embryos had lower total Myc than wild type embryos
(Figures 2 and 3). These data suggest that auto-repression can
reduce the naturally occurring, high levels of Myc to the point that
what remains in those embryos is ectopic Myc. If ectopic Myc is
low, total levels are low in those embryos. Consistent with these
low levels of Myc protein, we observed a phenotypic consequence
of the growth of these animals.
In support of our molecular data, we observed that larvae
heterozygous for Gal4 and UAS dmyc resembled larvae
zygotically null for dmyc [41]. In these experiments, we used a
Gal4 driver that allowed more embryos to survive and hatch into
larvae (P{Gal4}-da.G32, [42]) than survive with armGal4-UAS
dmyc. Many Gal4-da.G32-UAS dmyc embryos hatched into
viable larvae, however these larvae failed to grow, and after
approximately 3 days, died as small larvae (Figure 2C). These
larvae behaved as wandering third instars, and often died attached
to the side of the vial. Larvae heterozygous for Gal4, UAS dmyc
and UAS Su(z)2 together, however, hatched and grew normally,
Figure 2. Su(z)2 disrupts auto-repression by Myc. A) RT-PCR
analysis of endogenous, ectopic and total Myc expression in embryos of
four different genotypes, which are indicated above each lane
(Gal4=arm-Gal4, Gal4-Myc=armGal4; UAS dmyc, Gal4-Su(z)2=arm-
Gal4; Su(z)2XP, Gal4-Myc-Su(z)2=armGal4; Su(z)2XP; UAS dmyc). A 0–
21 hour collection of embryos was used for RNA isolation and for all
subsequent assays. Ras64B was used as a loading control. B) A chart
showing endogenous dmyc expression, the average of biological
triplicates is plotted with standard deviations indicated for four
genotypes of embryos. Expression was quantified using Quantity 1
(Bio-Rad). The blue line denotes a statistically significant change in
endogenous dmyc levels from Gal4-Myc to Gal4-Myc-Su(z)2. C) Living
larvae of the genotypes shown, all grown at low density, aged 4 days
after egg laying at room temperature, and photographed simulta-
neously.
doi:10.1371/journal.pone.0005076.g002
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repression by Su(z)2 (Figure 2C). These data illustrate the impact
of strong dmyc auto-repression, which is to induce a dmyc knock-
down phenotype, and that Su(z)2 appears to completely rescue this
mutant phenotype.
General repression by Myc is maintained and possibly
enhanced by Su(z)2
We were curious whether ectopic Su(z)2 interferes with general
repression by Myc at genes other than dmyc. We tested the
expression of 6 known embryonic repression targets of Myc
(Cyp6a8, CG31274, Obp56a, CG12868, CG31445, JhI-26
[16,26]) by RT-PCR using total RNA from embryos of the four
genotypes described above (Gal4, Gal4-UAS dmyc, Gal4-
Su(z)2XP, Gal4-UAS dmyc-Su(z)2XP). Two interesting results
were evident from these experiments.
First, all six genes were repressed in embryos with ectopic Myc,
despite a slight drop in overall Myc levels caused by auto-
repression (Figure 4A–B). This result occurred repeatedly and for
all 6 genes we tested. These data suggest that this set of six genes is
repressed by Myc in a mechanism that occurs before or
simultaneously with Myc repression of its own gene.
Second, these genes were also repressed in embryos with ectopic
Su(z)2, either alone or in combination of ectopic Su(z)2 and
ectopic Myc (Figure 4A–B). These results were also observed
repeatedly for six of six tested genes, and suggest that Su(z)2 not
only fails to interfere with repression by Myc but also appears to
replace it. One possible explanation for repression of these genes in
the presence of ectopic Su(z)2 alone is the status of endogenous
dmyc auto-repression in these embryos. Total Myc levels are
elevated in embryos with ectopic Su(z)2 alone compared to Gal4-
UAS dmyc embryos (Figures 2–3), suggesting the disruption of
endogenous dmyc auto-repression. It is possible that the disruption
of auto-repression causes increased Myc levels at a time when
these genes are sensitive to repression by Myc. Alternatively,
Su(z)2 alone may be sufficient for repression of these targets.
Taken together, our results show that Su(z)2 interferes with auto-
repression by Myc, but Su(z)2 appears not to affect and possibly to
enhance repression of other Myc targets.
Gene activation or repression can be a consequence of or
maintained by specific covalent histone modifications [43]. Tri-
methylated lysine 27 on histone 3 (H3K27-Me3) is a well defined
mark of PcG repression [44] and found to be present at Myc
activation and repression targets in wild type embryos [16,26]. To
test whether Su(z)2 affects this chromatin modification at Myc
repression targets, we performed chromatin immunoprecipitation
(ChIP) using antibodies specific for H3K27-Me3 (Millipore) in
four genotypes. We were surprised to find no difference in
methylation levels of the 6 repression targets in any of the four
genotypes. All six were consistently tri-methylated at H3K27 in all
four genotypes. We were further surprised to find reduced
H3K27-3Me at the dmyc locus in embryos with ectopic Myc
expression, inversely correlated with auto-repression (Figure 4C).
These data suggest that embryonic H3K27 tri-methylation at
these loci does not mediate their expression or repression.
However, the reduction of H3K27 tri-methylation of dmyc in
embryos expressing both ectopic Myc and ectopic Su(z)2 is
intriguing. One possibility to explain these results is that Myc auto-
repression utilizes a mechanism that involves removal of PcG
complexes from the locus.
Activation by Myc is enhanced by Su(z)2
We were interested in the downstream consequences of the
elimination of Myc auto-repression by Su(z)2, especially consid-
ering the dramatic phenotypes we observed in larvae. We tested
the expression of three known targets of Myc activation (CG14147,
Figure 3. dmyc auto-repression reduces total Myc protein levels compared to wild type, which is rescued by combining ectopic Myc
with ectopic Su(z)2 expression. Similarly aged embryos of four genotypes are beside one another, with the genotypes of embryos indicated
above each column. Anti-Myc staining is green.
doi:10.1371/journal.pone.0005076.g003
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the armGal4-UAS system as described above. Expression of
ectopic Myc led to auto-repression and therefore reduced
endogenous Myc levels. Upon reduction of endogenous Myc,
total Myc levels, consisting of the remaining endogenous plus
ectopic Myc, were lower in embryos expressing ectopic Myc than
wild type (Figure 5A). As a result, levels of all three tested
downstream activation targets were reduced in the effectively
Myc-knock-down embryos (Figure 5A). In embryos expressing
both ectopic Myc and Su(z)2, total Myc levels were high, similar to
levels in wild type embryos. Accordingly, the levels of all three Myc
activation targets are elevated, similar to their levels in wild type
embryos. We observed these results repeatedly, and using embryos
of various ages. These data show that, in embryos with both
ectopic Myc and ectopic Su(z)2, the loss of auto-repression leads to
an overall increase in Myc levels, which is sufficient to activate
downstream Myc targets. These gene expression changes help
explain the phenotypic rescue of Gal4-UAS dmyc-Su(z)2XP
animals.
We have previously published reports of strong activation by
Myc of hundreds of genes in embryos [16,26]. The difference
between those experiments and the ones we report here is that
levels of ectopic Myc are much lower in our newest experiments
than they have been previously. Because levels of ectopic Myc are
low, and because we still obtain auto-repression of the endogenous
locus, we have lower overall levels of Myc in embryos with ectopic
Figure 4. Ectopic Su(z)2 does not interfere with Myc repression of targets other than dmyc. A) A representative gel of RT-PCR data
showing the expression of six Myc targets of repression in four genotypes, as indicated above each column of bands. Total dmyc expression and
Ras64B expression, a loading and RNA level control, are shown in the bottom two panels. B) The average band intensities indicating levels of
expression and relative standard deviation are plotted for the 8 genes shown in A. Genotypes are indicated along the X axis, and the Y axis shows
band intensities as quantified by Quantity 1 (Bio-Rad). C) ChIP results showing H3K27 tri-methylation of three of the 8 genes shown in A, in the 4
genotypes of the experiment. Ras64B is a negative control. These data show a representative picture of biological triplicates for all 8 genes.
doi:10.1371/journal.pone.0005076.g004
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decrease in Myc activation of Myc targets. Therefore, our data
show the consequences of de facto knock-down of Myc levels on
Myc targets, which is that they are de-activated. The results are
consistent with these targets being Myc responsive, since their
levels drop as Myc levels drop. Our data are in agreement with
previous results, and add the novel result that Su(z)2 disruption of
auto-repression can alter downstream Myc function.
Figure 5. Increased Su(z)2 provides for activation of Myc targets, and a reduction in their H3K27 tri-methylation. A) RT-PCR analysis
showing expression of three Myc activation targets (indicated on the left side of the gel pictures) in embryos of 4 different genotypes (indicated
above the lanes). Average band intensities (Quantity 1) of biological triplicates are plotted on the right, with relative standard deviations indicated. B)
ChIP assay showing histone H3K27 tri-methylation at five Myc activation targets (indicated to the left of the gel pictures) in embryos of genotypes
indicated on top. Data shown on the left are plotted in a stacked column chart; the y-axis is the density of each PCR product divided by the density of
the input sample PCR product, and the values for each gene are stacked together for each of the four genotypes. These data show a representative
set of biological triplicates.
doi:10.1371/journal.pone.0005076.g005
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Myc targets
We have shown previously that embryonic targets of Myc
activation are tri-methylated at H3K27 [26]. To test whether Su(z)2
affects H3K27 chromatin modification at Myc activation targets,
we performed chromatin immunoprecipitation (ChIP) using
antibodies specific for H3K27-Me3 (Millipore). We used embryos
aged 0–21 hours, maintaining identical conditions to our RT-
PCR experiments shown in Figure 5A, and used ChIP DNA as
template for PCR amplification of several genes: CG14147,
CG7330, Cyp309a2, SamDC and 128up. The first two represent
the set that were activated with ectopic Myc and Su(z)2
(Figure 5A). Cyp309a2 is activated by Myc at mid embryogenesis
but not later [Goodliffe, unpublished and 16,26], and SamDC and
128up have both been reported to respond to Myc in Drosophila
and have Myc bound at their promoters [45].
In the absence of ectopic Myc, four out of five Myc activation
targets were methylated at H3K27 (Figure 5B). Upon ectopic Myc
induction, and under conditions of de-activation caused by a
reduction in total Myc levels (as in Figure 5A), all five loci showed
increased H3K27 methylation (Figure 5B). These results indicate
that reduced Myc levels lead to increased H3K27-3Me at Myc
activation targets. Consistent with a Su(z)2-induced increase in
total Myc levels, HeK27-Me3 decreased in embryos having both
ectopic Myc and Su(z)2 (Figure 5B). These data are consistent with
our RT-PCR results and indicate that activation of these targets
involves reduced H3K27 tri-methylation, and that ectopic Su(z)2
may impact this reduction. Interestingly, at three of the five loci,
ectopic Su(z)2 alone reduces H3K27-Me3 levels compared to their
levels in Gal4 embryos (CG14147, Cyp309a2, 128up).
Discussion
Su(z)2 has two mammalian homologs: Bmi-1 and Mel-18
[29,38]. Bmi-1 was originally isolated as a collaborator with Myc
in tumorigenesis [46,47], and Myc has been shown to directly
activate Bmi-1 [48]. Interestingly, Mel-18 behaves as a tumor
suppressor by repressing oncogenes Bmi-1 and c-myc in mammals
[49,50]. However, Mel-18 and Bmi-1 have both been shown to
increase proliferation and survival of cancer cells [51].
We have shown that auto-repression of dmyc expression in
embryos is a potent mechanism that can persist throughout
embryogenesis, and that Su(z)2 disrupts this mechanism. These
results explain, in part, the role of Polycomb in Myc auto-
repression, which involves suppression of Su(z)2 expression. We
had previously reported that Pc RNAi up-regulated many genes
that are also up-regulated upon increased total Myc levels [16]. Our
data suggest that the intermediate between those sets of genes is
likely to be Su(z)2: Su(z)2 levels increase without Pc, followed by
the disruption of dmyc auto-repression, leading to an increase in
Myc levels and the subsequent activation of Myc targets.
We are intrigued that a repressor interferes with repression, and
specifically the auto-repression of the dmyc gene and not other
Myc repression targets. Our results suggest different mechanisms
for dmyc auto-repression and repression by Myc in general. In the
former case, the expression of Su(z)2 somehow interferes with
auto-repression mediated by ectopic Myc, and in the latter case,
Su(z)2 appears not to affect and possibly replace repression by
ectopic Myc. Because it is unlikely that a potent repressor such as
Su(z)2 directly interferes with repression, we suppose that its role in
interference with auto-repression is indirect. There may be a gene
that is responsive to the combination of elevated Su(z)2 and
elevated Myc, and this gene product may interfere with auto-
repression.
We have not ruled out the possibility, however, that the over-
expression of Su(z)2 caused it to replace Psc in the Polycomb
Repressive Complex 1 (PRC1). Although Psc and Su(z)2 have
been shown to be functional homologs in that complex [37], an
embryonic Su(z)2-PRC1 complex may be targeted differently than
a PRC1 complex containing Psc, and therefore potentially remove
other components of the PRC1 complex from the dmyc locus. It is
also possible that increased Su(z)2 protein levels titrate members of
PRC1, causing non-functional complexes to accumulate and
interfere with functional complexes.
We use whole embryos for our experiments because we are
interested in the endogenous, embryonic mechanisms that allow
an embryo to tolerate high levels of Myc. We have shown that
auto-repression is potent and can induce a dmyc knock-down
phenotype. We suspect that the wild type role of Su(z)2’s
interference of dmyc auto-repression is important for the
prevention of complete silencing of dmyc. Embryos require Myc
protein for growth, and our results show that Su(z)2 helps maintain
expression of dmyc, providing Myc levels necessary for embryonic
growth and proliferation.
Materials and Methods
Drosophila stocks and crosses
We crossed females homozygous for a Gal4 driver (armGal4
[52] or Gal4-da.G32 [42]) to males homozygous for UAS dmyc
[53], Su(z)2XP (P[XP]d01221, see flybase.org for further infor-
mation), and UAS dmyc-Su(z)2XP. As controls, we crossed Gal4
females to Gal4 males.
Microarray data normalization and analysis
The microarray data plotted in Figure 1 has been published
previously; see Goodliffe et al. (2007) for normalization and data
treatment.
RNA isolation and RT-PCR
We conducted crosses as described, and collected embryos on
grape juice agar plates (Genesee) supplemented with live yeast.
Total RNA was isolated using TRIzol (Invitrogen), and RNA
samples were DNAse treated (Promega) prior to RT-PCR. We
used AccessQuick RT-PCR system (Promega) to amplify target
transcripts from RNA, and quantified band intensities using
Quantity 1 (Bio-Rad). PCR cycles were minimized to examine
expression changes within the linear range (24–25 cycles,
depending on the primer set).
We isolated RNA from embryos aged 0–21 hours, and
examined expression levels of endogenous dmyc expression using
a primer set that amplifies the 59 untranslated region of dmyc,
which is absent in the UAS dmyc transgene [16]. To amplify
ectopic myc expression, we used a primer that binds to the 9E10
epitope tag present on the transgenic transcript. All experiments
were done in biological triplicates, with no more than 25 PCR
cycles.
Chromatin immunoprecipitation
ChIP was performed as described previously [16,26]. We used
antibodies at a 1:100 concentration, amplified target genes using
GoTaq Hot-Start polymerase (Promega), and quantified band
intensities using Quantity 1 (Bio-Rad). Anti-H3K27-3Me is
obtained from Millipore, 07-449.
Embryo fixation, staining and microscopy
Embryos were fixed in formaldehyde/PBS, and stained using
1:250 concentration of anti-Myc (Santa Cruz) in PBS/0.1%
Su(z)2 Affects Myc
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1:500 dilution (AlexaFluor 488 anti-rabbit, Invitrogen). Embryos
were mounted in SlowFade Gold with DAPI (Invitrogen), and
imaged using a Motic BA400 compound microscope, Lumen 200
Illumination Systems epi-fluorescence, Spot Cooled CCD mono-
chrome camera and software. We photographed all embryos with
identical bulb intensity and acquisition settings.
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